Canbex Therapeutics Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Canbex Therapeutics Ltd - overview
Established
2005
Location
London, England, UK
Primary Industry
Pharmaceuticals
About
Canbex Therapeutics Ltd is dedicated to the development of novel compounds for the treatment of spasticity in multiple sclerosis (MS) and potentially other disorders.
Current Investors
Wellcome Trust, M Ventures, UCL Business plc
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.canbex.co.uk
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Canbex Therapeutics Ltd - financials
| Fiscal Year Ended | Jul 31, 2010 | Jul 31, 2011 | Jul 31, 2012 | Jul 31, 2013 | Jul 31, 2014 | Jul 31, 2015 | Jul 31, 2016 | Jul 31, 2017 | Jul 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 113,670 | 107,675 | 112,015 | 739,880 | 61,042 | - | - | - |
| % Revenue Growth (YoY) | - | - | (5.3%) | 4.0% | 560.5% | (91.7%) | - | - | - |
| EBITDA (USD) | (72,381) | (160,832) | (666,155) | (654,561) | (1,048,582) | (1,849,289) | - | - | - |
| Operating Income (USD) | (72,381) | (160,832) | (666,155) | (654,561) | (1,048,838) | (1,849,545) | - | - | - |
| Operating Margin | - | (141.5%) | (618.7%) | (584.4%) | (141.8%) | (3030.0%) | - | - | - |
| % EBITDA Margin | - | (141.5%) | (618.7%) | (584.4%) | (141.7%) | (3029.5%) | - | - | - |
| NET Income (USD) | (110,468) | (198,977) | (724,167) | (512,059) | (884,640) | (1,663,483) | - | - | - |
| % Net Margin | - | (175.0%) | (672.5%) | (457.1%) | (119.6%) | (2725.1%) | - | - | - |
Canbex Therapeutics Ltd - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Canbex Therapeutics Ltd | - | ||||||||
| Grant | Completed | Canbex Therapeutics Ltd | - | ||||||||
| Series A | Completed | Canbex Therapeutics Ltd | - | ||||||||
| Seed | Completed | Canbex Therapeutics Ltd | - |
Displaying 1 - 4 of 4
Canbex Therapeutics Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.